Amgen Inc

Iconic Profile

Amgen Inc (AMGN) is a leading biotechnology company focused on the development and commercialization of innovative therapies for serious illnesses. With a market capitalization of $197.4 billion, Amgen specializes in biologics and biosimilars, targeting areas such as oncology, nephrology, and inflammatory diseases. The company leverages advanced genetic and molecular biology techniques to create groundbreaking treatments, positioning itself as a key player in the healthcare sector. Amgen's robust pipeline and established portfolio of blockbuster drugs, including therapies like Enbrel and Neulasta, underscore its significant role in addressing unmet medical needs. As a pioneer in biotechnology, Amgen not only contributes to advancements in patient care but also plays a vital role in shaping the future of healthcare through innovation and research.